this company is all about home mow feela, so for those of you who don't know about home mow feela, it'sastating disease that prevents blood clotting. which means that even a paper cut can result in tremendous bleeding. plus it can also cause extreme bruising, spontaneous bleeding and joint disease. there's actually two different types of hemophilia. at first since these treatments got approved, it's sales have been growing like a weed. biovaritiv is not the only game in town, as other companies are close to getting their own ho hemophilia drugs on the market. how come biogen wanted to spin it off in the first place? most of biogen's business is -- world class hemophilia franchises and more exciting compounds in the pipeline. the thing is hemophilia is a blood disorder, that doesn't have much in common with bioveritiv. it employs totally different kinds of doctors, it's not necessarily having much gain by keeping these two businesses under the same roof, but management figured that by splitting them up, each company could focus more effort on what it does best. also these home home mow k